YZOFF yields 3.66% · JNJ yields 2.13%● Live data
📍 YZOFF pulled ahead of the other in Year 1
Combined, YZOFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YZOFF + JNJ for your $10,000?
Yangtze Optical Fibre And Cable Joint Stock Limited Company researchs, develops, produces, and sells optical fiber and cable products in the People's Republic of China and internationally. The company operates in two segments, Optical Fibres and Optical Fibre Preforms, and Optical Fibre Cables segments. It also provides copper wire and related products; integrated wiring systems; technical development consulting services for computer hardware and software and ancillary equipment; and vapor and chemical raw materials. In addition, the company imports, exports, and sells submarine cables, optical cables, and other power cables and their accessories, as well as trades in raw materials; and installs cables, accessories, and systems related to various submarine projects. Further, it designs, produces, and sells optical communication equipment and electrical products, as well as provides integrated services in communication, computer, intelligent building, weak current system, and software development. Additionally, the company engages in research and promotion of medical materials, as well as provides general contracting engineering services. Yangtze Optical Fibre And Cable Joint Stock Limited Company was founded in 1988 and is headquartered in Wuhan, the People's Republic of China.
Full YZOFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.